Prem Watsa - Fairfax Financial Holdings
Holding/activity history for Xeris Pharmaceuticals Inc. (XERS)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price |
| 2024 Q3 | 170,937 | 0.04 | $2.84 | ||
| 2024 Q2 | 170,937 | 0.03 | Add 12.91% | 0.00 | $2.24 |
| 2024 Q1 | 151,395 | 0.03 | $2.20 | ||
| 2023 Q4 | 151,395 | 0.02 | $2.35 | ||
| 2023 Q3 | 151,395 | 0.02 | $1.86 | ||
| 2023 Q2 | 151,395 | 0.03 | $2.61 | ||
| 2023 Q1 | 151,395 | 0.02 | $1.62 | ||
| 2022 Q4 | 151,395 | 0.01 | $1.32 | ||
| 2022 Q3 | 151,395 | 0.01 | $1.56 | ||
| 2022 Q2 | 151,395 | 0.01 | $1.53 | ||
| 2022 Q1 | 151,395 | 0.01 | $2.56 | ||
| 2021 Q4 | 151,395 | 0.01 | Buy | 0.01 | $2.91 |